iRhythm Technologies has been granted a patent for a wearable device that can monitor physiological signals and assess the likelihood of arrhythmia in a user. The device includes a housing, battery terminal connector, conductive traces, and an insulator for recording signals. The device utilizes a sensor to detect physiological signals and a battery terminal connector with conductive traces and an insulator to connect the battery and circuit board. GlobalData’s report on iRhythm Technologies gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on iRhythm Technologies, Treatment progress monitoring was a key innovation area identified from patents. iRhythm Technologies's grant share as of September 2023 was 51%. Grant share is based on the ratio of number of grants to total number of patents.
Wearable device for monitoring physiological signals and detecting arrhythmia
A recently granted patent (Publication Number: US11751789B2) describes a wearable device designed to monitor physiological signals in a user. The device includes at least one battery with terminals on opposite sides, a sensor for detecting physiological signals, and a battery terminal connector. The battery terminal connector consists of conductive traces on different surfaces and an insulator positioned on these surfaces.
The wearable device also features a housing that encloses a hardware processor and the battery. Additionally, it includes an adhesive flexible wing extending from the housing. The first conductive trace on the battery terminal connector is configured to connect to the first terminal of the battery, while the second conductive trace connects to the second terminal.
The insulator serves to separate the first conductive trace from both the second terminal of the battery and the second conductive trace. The battery terminal connector is designed to present both conductive traces on its second surface for electric coupling to a hardware processor.
The first surface of the battery terminal connector faces towards the battery, while the second surface extends over the different portions of the connector and faces away from the battery. The bottom portion of the battery terminal connector is referred to as the first portion, while the top portion is the second portion.
The second conductive trace is disposed on both the inner and outer surfaces of the insulator. The inner and outer portions of the second conductive trace are electrically connected by one or more vias that extend through the insulator and are filled with conductive material. This conductive material may differ from the material used for the insulator and the first and second conductive traces, or it may be the same.
Overall, this patent describes a wearable device that utilizes a unique battery terminal connector design to monitor physiological signals in a user. The device includes a sensor, a battery, a housing enclosing a hardware processor, and an adhesive flexible wing. The conductive traces and insulator in the battery terminal connector ensure proper electrical connections and isolation. This innovation may have implications for the development of wearable devices in the healthcare and fitness industries.